Zimmer Biomet (ZBH) Stock Price & AI Analysis

$95.21
$0.10
(0.11%)
Health Care Equipment

NYSE USA

May 12, 9:31 PM EDT
  • Market Cap.
    18.84B
  • Volume
    3.44M
  • Avg. Volume
    2.18M
  • Target Price
    $106.80
  • 52W Range
    89.92 - 122.25
  • RSI (14)
    38.9
  • Beta
    0.77
  • PEG Ratio
    5.01
  • SMA 20
    -3.41%
  • SMA 50
    -8.99%
  • SMA 200
    -10.89%
  • Insider Owner
    0.14%
  • Insider Trans
    -0.52%
  • Institution Owner
    93.69%
  • Institution Trans
    1.19%
  • Short Interest
    6.27%
  • EPS next Y
    4.27

Zimmer Biomet Company Profile

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Zimmer Biomet | Latest news

Zimmer Biomet Holdings' (NYSE:ZBH) Conservative Accounting Might Explain Soft...

The most recent earnings report from Zimmer Biomet Holdings, Inc. (NYSE:ZBH) was disappointing for...

Simply Wall St - 15 hours ago

Investing in Zimmer Biomet Holdings Inc

As a result of the transaction, Yi Sang now holds 5,322 shares, worth roughly $0.51 million. JP Morgan upgraded its Zimmer Biomet Holdings Inc [ZBH] rating to an Overweight from a a Neutral ...

Knox Daily - 19 hours ago

Zimmer Biomet Holdings, Inc. (ZBH): Among the Best Medical Device Stocks to Buy...

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are...

Insider Monkey - 4 days ago

Raymond James Cuts Zimmer Biomet (NYSE:ZBH) Price Target to $104.00

Zimmer Biomet (NYSE:ZBH – Free Report) had its target price trimmed by Raymond James from $119.00 to $104.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has an outperform ...

ETF DAILY NEWS - 4 days ago

Royal Bank of Canada Lowers Zimmer Biomet (NYSE:ZBH) Price Target to $112.00

Zimmer Biomet (NYSE:ZBH – Get Free Report) had its price objective lowered by investment analysts at Royal Bank of Canada from $125.00 to $112.00 in a research report issued to clients and investors ...

ETF DAILY NEWS - 5 days ago

Zimmer Biomet Holdings (NYSE:ZBH) Q1 Earnings Rise, Revises 2025 Revenue...

Zimmer Biomet Holdings (NYSE:ZBH) recently reported solid financial performance, with increased...

Simply Wall St - 6 days ago

Roth Capital Forecasts Weaker Earnings for Zimmer Biomet

Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) – Equities research analysts at Roth Capital cut their Q2 2025 earnings per share estimates for shares of Zimmer Biomet in a research note ...

ETF DAILY NEWS - 3 days ago

Zimmer Biomet Holdings Inc (ZBH) Q1 2025 Earnings Call Highlights: Navigating...

Zimmer Biomet Holdings Inc (ZBH) reports steady revenue growth and strategic advancements despite...

GuruFocuscom - 7 days ago

Zimmer Biomet Holdings First Quarter 2025 Earnings: EPS Beats Expectations

Zimmer Biomet Holdings (NYSE:ZBH) First Quarter 2025 Results Key Financial Results Revenue: US$1.91b...

Simply Wall St - 7 days ago

Wells Fargo & Company Issues Pessimistic Forecast for Zimmer Biomet (NYSE:ZBH)...

Zimmer Biomet (NYSE:ZBH – Get Free Report) had its price target lowered by analysts at Wells Fargo & Company from $113.00 to $98.00 in a note issued to investors on Tuesday, MarketBeat reports ...

ETF DAILY NEWS - 5 days ago